Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 31.03.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
31.03.23BlackRock Announces Name Changes for Five Closed-End Funds with Contingent Limited Terms: BlackRock Science and Technology Trust II, BlackRock Health Sciences Trust I, BlackRock Capital Allocation Trust, BlackRock Innovation and Growth Trust and ...541NEW YORK--(BUSINESS WIRE)--BlackRock Advisors, LLC ("BlackRock") announced today name changes for five BlackRock closed-end funds with contingent limited terms (each, a "Trust"). The name changes are...
► Artikel lesen
31.03.23Acquisition of Volta Inc. by Shell USA, Inc., a subsidiary of Shell plc, Complete192NEW YORK--(BUSINESS WIRE)--Volta Inc. ("Volta") today announced that Shell USA, Inc., a subsidiary of Shell plc, has completed the previously announced acquisition of Volta in an all-cash transaction....
► Artikel lesen
31.03.23Firsthand Technology Value Fund Announces Fiscal Year Financial Results, NAV of $4.44 Per Share330SAN JOSE, Calif.--(BUSINESS WIRE)--Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the "Fund"), a publicly traded venture capital fund that invests in technology and cleantech companies,...
► Artikel lesen
31.03.23bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results495SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases...
► Artikel lesen
31.03.23Applied UV Reports Financial Results for Full Year 20221.179MOUNT VERNON, N.Y.--(BUSINESS WIRE)--Applied UV, Inc. (NasdaqCM: AUVI) ("Applied UV" or the "Company"), a global leading provider of patented, scientifically and clinically proven surface and air...
► Artikel lesen
31.03.23Lithium Royalty Corp. Reports 2022 Results378TORONTO--(BUSINESS WIRE)--Lithium Royalty Corp. (TSX: LIRC): (in U.S. dollars unless otherwise noted) Lithium Royalty Corp. (TSX: LIRC) ("LRC" or the "Company") is pleased to report its annual...
► Artikel lesen
31.03.23Williams Industrial Services Group Inc. Reports Fourth Quarter Financial Results460ATLANTA--(BUSINESS WIRE)--Williams Industrial Services Group Inc. (NYSE American: WLMS) ("Williams" or the "Company"), an energy and industrial infrastructure services company, today reported financial...
► Artikel lesen
31.03.23Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update692DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided...
► Artikel lesen
31.03.23AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results335ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial...
► Artikel lesen
31.03.23Flora Growth Reports 2022 Year-End Financial Results: $37.2M in Revenue, 314% Growth Year-Over-Year795FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) ("Flora' or the "Company"), a leading cultivator, manufacturer and distributor of global cannabis products and brands,...
► Artikel lesen
31.03.23Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update699EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead...
► Artikel lesen
31.03.23KANEKA CORPORATION: KANEKA: "Entwicklung einer Polymersynthese-Technologie durch Mikroorganismen unter Verwendung von CO2 als direktem Rohstoff" als Projekt des NEDO Green Innovation Fund ausgewählt736Kaneka Corporation (Hauptsitz: Minato-ku, Tokio; President: Minoru Tanaka; im Folgenden "Kaneka"), Bacchus Bio innovation Co., Ltd (Hauptsitz: Kobe-Stadt, Hyogo; President: Mikio Tanji, im Folgenden...
► Artikel lesen
31.03.23Dynacor Group Inc.: Dynacor 2022: Unternehmen meldet seinen 12. Jahresgewinn in Folge mit einem Nettogewinn von 12,0 Mio. USD (0,31 USD bzw. 0,40 CA$ pro Aktie), einschließlich eines jährlichen Goldproduktionsrekords von über 110.000 Unzen AuEq668Dynacor Group Inc. (TSX: DNG) ("Dynacor" oder das "Unternehmen") hat seinen geprüften konsolidierten Jahresabschluss sowie die Management's Discussion and Analysis (MD&A) für das am 31. Dezember...
► Artikel lesen
31.03.23Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 31 March 2023439Regulatory News: Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) ("PSH") today announced that it has purchased, through PSH's agent, Jefferies International Limited ("Jefferies"), the...
► Artikel lesen
31.03.23ABIONYX Pharma Announces Its Strategy in Ophthalmology and New Positive Preclinical Results for the Deployment of Two Innovative Technology Platforms: Apotherapy and Biovectorization473Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-related side effects when used in...
► Artikel lesen
31.03.23AM Best Downgrades Issuer Credit Rating of MS Amlin AG503AM Best has downgraded the Long-Term Issuer Credit Rating (Long-Term ICR) to "a" (Excellent) from "a+" (Excellent) and affirmed the Financial Strength Rating (FSR) of A (Excellent) of MS Amlin AG...
► Artikel lesen
31.03.23Azelis Share Buyback Program 2023 - Update948Regulatory News: In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Azelis Group NV (the "Company" or "Azelis") (Brussels:AZE)...
► Artikel lesen
31.03.23AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer's Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD 2023)325AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer's disease...
► Artikel lesen
31.03.23FUJIREBIO EUROPE: Fujirebio erweitert sein Portfolio an vollautomatischen blutbasierten Biomarkern um die vollautomatischen Lumipulse G ApoE4- und Lumipulse G Pan-ApoE-Assays ausschließlich für den Forschungsgebrauch305Die H.U. Group Holdings Inc. und ihre hundertprozentige Tochtergesellschaft Fujirebio haben heute die Verfügbarkeit der Lumipulse G ApoE4- und Lumipulse G Pan-ApoE-Assays für die vollautomatischen...
► Artikel lesen
31.03.23Tivic Health Reports Fiscal Year 2022 Financial Results260SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine...
► Artikel lesen
Seite:  Weiter >>